Nissay Asset Management Corp Japan Has $51.18 Million Stock Position in Astera Labs, Inc. $ALAB

Nissay Asset Management Corp Japan lifted its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 79.6% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 105,965 shares of the company’s stock after acquiring an additional 46,952 shares during the quarter. Nissay Asset Management Corp Japan owned approximately 0.06% of Astera Labs worth $51,183,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Keating Financial Advisory Services Inc. acquired a new stake in Astera Labs during the 2nd quarter worth approximately $25,000. Archer Investment Corp bought a new position in Astera Labs in the 2nd quarter worth approximately $30,000. Transamerica Financial Advisors LLC bought a new stake in shares of Astera Labs during the 2nd quarter valued at about $35,000. Johnson Financial Group Inc. purchased a new position in shares of Astera Labs in the second quarter worth about $43,000. Finally, Bell Investment Advisors Inc purchased a new stake in shares of Astera Labs in the 2nd quarter worth about $43,000. 60.47% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

ALAB has been the subject of a number of analyst reports. Weiss Ratings reiterated a “hold (c)” rating on shares of Astera Labs in a research note on Tuesday, August 18th. TD Cowen reduced their price objective on Astera Labs from $425.00 to $375.00 and set a “hold” rating for the company in a research note on Wednesday, August 5th. Barclays lifted their price objective on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research note on Monday, July 20th. Zacks Research raised Astera Labs from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 11th. Finally, Jefferies Financial Group upped their price objective on shares of Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $340.53.

Insider Activity

In other news, Director Jack R. Lazar sold 10,000 shares of the business’s stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $355.17, for a total value of $3,551,700.00. Following the transaction, the director directly owned 75,688 shares in the company, valued at $26,882,106.96. The trade was a 11.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 90,630 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the sale, the chief operating officer directly owned 1,119,038 shares of the company’s stock, valued at $380,864,583.30. The trade was a 7.49% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders have sold 419,244 shares of company stock valued at $163,135,169. 10.40% of the stock is currently owned by insiders.

Astera Labs Price Performance

Astera Labs stock opened at $289.47 on Friday. The firm has a market cap of $50.22 billion, a price-to-earnings ratio of 143.30 and a beta of 3.84. The firm has a fifty day moving average price of $342.38 and a two-hundred day moving average price of $249.65. Astera Labs, Inc. has a fifty-two week low of $97.89 and a fifty-two week high of $499.48.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. During the same period last year, the firm earned $0.44 EPS. The business’s revenue for the quarter was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, sell-side analysts expect that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.